Overview

Safety and Efficacy of K-134 for the Treatment of Intermittent Claudication

Status:
Completed
Trial end date:
2010-07-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the safety and efficacy of K-134 for the treatment of intermittent claudication.
Phase:
Phase 2
Details
Lead Sponsor:
Kowa Research Institute, Inc.
Treatments:
Cilostazol